Local vascular delivery of probucol in combination with sirolimus
    1.
    发明授权
    Local vascular delivery of probucol in combination with sirolimus 有权
    普罗布考联合西罗莫司的局部血管输送

    公开(公告)号:US09265597B2

    公开(公告)日:2016-02-23

    申请号:US13972479

    申请日:2013-08-21

    申请人: Wyeth LLC

    摘要: Medical devices, and in particular implantable medical devices, may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and/or compounds from the implantable medical devices.

    摘要翻译: 医疗装置,特别是可植入医疗装置,可以涂覆任何数量的生物相容性材料。 治疗药物,药剂或化合物可以与生物相容性材料混合并固定在医疗装置的至少一部分上。 这些治疗药物,药剂或化合物还可以进一步减少生物体对将生物体引入医疗装置的反应。 此外,这些治疗药物,药剂和/或化合物可用于促进愈合,包括血块的形成。 此外,可以修改装置以促进内皮化。 可以使用各种材料和涂覆方法来将药物,试剂或化合物维持在医疗装置上,直到输送和定位。 此外,可以使用各种聚合物组合来控制来自可植入医疗装置的治疗药物,药剂和/或化合物的洗脱速率。